Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults (NCT05961319) | Clinical Trial Compass
CompletedNot Applicable
Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults
Canada21 participantsStarted 2023-09-20
Plain-language summary
This project aims to address the impact of frailty on older adults, particularly its connection to cognitive impairments such as dementia. By identifying frailty in its early stages, interventions can be designed to slow down the progression of cognitive decline. To achieve this, the project plans to develop a reliable at-home monitoring system that can accurately track frailty in older adults with mild cognitive impairment or dementia. By utilizing cutting-edge technologies such as high-precision indoor positioning and home-installed sensors, referred to as zero-effort technologies (ZETs), the system will collect continuous sensor data, which will be analyzed to identify indicators of frailty.
Who can participate
Age range
60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* In-patients at the Glenrose Rehabilitation Hospital (GRH) and GRH' visitors or staff (e.g. patients' caregivers, relatives, friends of older adults in-patient or staff at the GRH who are interested in participating) who are 65 years old or older
* For in-patients who are pre-frail or frail according to the scale used at the GRH (can be equivalent to Fried's scale pre-frail/frail (score = 1 - 4). For GRH's visitors or staff, are robust according to Fried's Frail Scale (score=0) as per the definition in (Fried, 2001)
* With or without some level of cognitive impairment (Standardized mini-mental state examination (MMSE) of 21 to 30 ("mild" (24-21) to "could be normal" (25-30)) or the equivalent in the screening tool.
* Have a cognitive ability to interact with the frailty sensors (i.e. scale, dynamometer, smart speaker).
* Have a functional vision and hearing with or without aides (glasses/hearing aids) to be able to interact with furniture and sensors at the ILS and to fill out questionnaires.
* Have functional upper extremity function to be able to interact with furniture and sensors at the ILS.
* Be able to walk independently 15 meters with or without a walking aid.
* If taking antidepressants or narcotics, participants have no changes in the medication for at least 3 months
Exclusion Criteria:
* Those with a history of Parkinson's disease or other movement disorders or stroke.
Justification: Movement disorders causing tremors will affect data collec…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Slowness (Mobility)
Timeframe: through study completion, within a total average of 2 hours
2
Weight (lbs, Kgs)
Timeframe: through study completion, within a total average of 2 hours
3
Exhaustion
Timeframe: through study completion, within a total average of 2 hours
4
Strength - Handgrip
Timeframe: through study completion, within a total average of 2 hours
5
Activity
Timeframe: through study completion, within a total average of 2 hours
6
Meal Preparation
Timeframe: through study completion, within a total average of 2 hours
7
Observe Free Activity
Timeframe: through study completion, within a total average of 2 hours